✦ LIBER ✦

512 Darifenacin is effective in improving the major symptoms of overactive bladder: A pooled analysis of phase III studies

✍ Scribed by C. Chapple

Book ID: 118645721
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 201 KB
Volume: 3
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(04)90509-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Overactive Bladder in the O

Treatment of Overactive Bladder in the Older Patient: Pooled Analysis of Three Phase III Studies of Darifenacin, an M3 Selective Receptor Antagonist

✍ Jenelle Foote; Karin Glavind; Georg Kralidis; Jean-Jacques Wyndaele 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

558Approaches for determining the effica

558Approaches for determining the efficacy of treatment for overactive bladder: Assessment of responder rates to darifenacin INA pooled analysis of phase III studies

✍ P. Abrams; K. Lheritier; M. Steel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Efficacy and Tolerability of Fesoterodin

Efficacy and Tolerability of Fesoterodine in Men With Overactive Bladder: A Pooled Analysis of 2 Phase III Studies

✍ Sender Herschorn; J. Stephen Jones; Matthias Oelke; Scott MacDiarmid; Joseph T. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 337 KB

## Objectives: To assess the efficacy, safety, and tolerability of fesoterodine 4 and 8 mg in men with overactive bladder. ## Methods: This was a subanalysis of pooled data from 358 men enrolled in 2 double-blind, placebo-controlled phase iii trials. subjects with frequency and urgency or urgency

A pooled analysis of three phase III stu

A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder

✍ Christopher Chapple; William Steers; Peggy Norton; Richard Millard; Georg Kralid 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

401 The incidence of antimuscarinic-asso

401 The incidence of antimuscarinic-associated side effects in overactive bladder (OAB) patients treated with mirabegron: Results of a pooled analysis of 3 randomised phase 3 trials

✍ Nitti, V.; Chapple, C.R.; Amarenco, G.; Radziszewski, P.; Angulo, J.; Blauwet, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 294 KB

A Phase III, Randomized, Double-blind, P

A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder

✍ Herschorn, Sender; Barkin, Jack; Castro-Diaz, David; Frankel, Jeffrey M.; Espuna 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 407 KB